Cancer immunology and immunotherapy

Open Access
Tumor microenvironment-responsive polymeric nanoparticles for enhanced immunotherapy
Yongxin Zhang, Shaobing Zhou and Jingya Zhao

Cancer Biology & Medicine April 2026, 23 (4) 461-469; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0517
Open Access
Design principles of nanomaterials for cancer immunotherapy: a mechanistic framework across the cancer immunity cycle
Yating Bai, Zhihao Lan, Nana Feng, Zhanzhan Zhang and Yang Liu

Cancer Biology & Medicine April 2026, 23 (4) 541-558; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0737
Open Access
Integrative multi-omic analysis identified ERBB2 mutations and senescence-driven immune suppression as dual therapeutic targets in LAR triple-negative breast cancer
Yaxin Zhao, Han Wang, Ying Wang, Yizhou Jiang, Xin Hu and Zhiming Shao

Cancer Biology & Medicine March 2026, 23 (3) 374-391; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0691
Open Access
Precision immunotherapy for breast cancer: from biomarkers to clinical practice
Jie Mei, Kai Yang, Xinkang Zhang, Xiang Huang and Yongmei Yin

Cancer Biology & Medicine March 2026, 23 (3) 320-326; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0815
Open Access
Advances in TROP2-targeted antibody-drug conjugates for breast cancer therapy: into the new era
Kuikui Jiang and Shusen Wang

Cancer Biology & Medicine March 2026, 23 (3) 327-337; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0504
Open Access
Protocol and statistical designs in classic clinical research—toripalimab series trial analysis
Yingjian He, Li Bian and Zefei Jiang

Cancer Biology & Medicine March 2026, 23 (3) 338-342; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0759
Open Access
Applying microfluidic technology to interpret the tumor immune microenvironment and cancer immunotherapy
Xuhong Chen, Dongxian Tan, Shuaiting Liu, Ruolin Luo, Yang Liu, Miaomiao Zhang, Siqi Li and Jing Xu

Cancer Biology & Medicine February 2026, 23 (2) 169-185; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0541
Open Access
Targeting tumor-infiltrating regulatory T cells based on immunometabolism
Na Li and Dexue Tian

Cancer Biology & Medicine February 2026, 23 (2) 186-200; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0645
Open Access
First-line immunotherapy for advanced HER2-negative gastric cancer: differences between Asian and non-Asian patients
Chuanhua Zhao, Sisi Ye, Meng Chen, Jing Qian and Jianming Xu

Cancer Biology & Medicine February 2026, 23 (2) 201-217; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0398
Open Access
Identification of immune reconstitution and hematopoiesis restoration by scRNA-seq in bone marrow of multiple myeloma patients treated with high-dose melphalan following auto-HSCT
Qian Li, Yaling Wang, Hongfeng Yuan, Qiaomei Cai, Lina Zhao, Li Lin, Shuang Gao, Lin Chen, Zhiying Zhang, Jing Ma, Su Liu, Zeng Cao, Haifeng Zhao, Yufei Wang, Shihui Li, Pan Lv, Huihui Zhang, Guowen Wang, Guang Yang, Xiaodong Zhang and Yafei Wang

Cancer Biology & Medicine February 2026, 23 (2) 247-251; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0585

Main menu

User menu

Search

Cancer immunology and immunotherapy

Pages

Navigate

More Information

For Authors

Journal Services